Skip to main content

Table 4 Treatment Mode by Study Arm and Round (%)

From: Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial

 

Correct Treatment

Incorrect Treatment

MDs asks patient preference (PP) (%)

No prostate cancer treatment (NT) (%)

Overall

Cont.

Interv.

Cont.

Interv.

Cont.

Interv.

Cont.

Interv.

Round 1

17.9%

21.6%

22.4%

29.1%

25.5%

22.0%

34.2%

27.3%

Round 2

18.5%

29.1%

25.3%

21.1%

40.4%

32.7%

15.7%

17.1%

D in D estimation

6.9%

−10.8%

−4.3%

8.2%

p-value

0.001

0.028

0.210

0.021